Abstracts tagged "MRI"

Abstract Number: 241 • 2013 ACR/ARHP Annual Meeting
Exploratory Factor Analysis Of a Parsimonious Medial Cartilage Damage Index Reveals One Factor Associated With Radiographic Severity and Symptoms: Data From The Osteoarthritis Initiative
Grace H. Lo¹, Lori Lyn Price^2,3, Ming Zhang⁴, Jeffrey B. Driban⁵, Daniel Harper⁴ and Timothy E. McAlindon⁶, ¹VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Medical Care Line and Research Care Line; Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁴Rheumotology, Tufts Medical Center, Boston, MA, ⁵Rheumatology, Tufts Medical Center, Boston, MA, ⁶Division of Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: The cartilage damage index (CDI) is a parsimonious method of measuring articular cartilage approximating regional cartilage volume based on 18 locations within the knee,…
Abstract Number: 1800 • 2013 ACR/ARHP Annual Meeting
Persistent Fatty Lesions In The Vertebrae In Ankylosing Spondylitis Favor Subsequent New Syndesmophytes: Imaging Results Of a Phase III, Randomized, Placebo-Controlled Study
Kay-Geert A. Hermann¹, Xenofon Baraliakos², Jürgen Braun³, Stephen Xu⁴ and Benjamin Hsu⁴, ¹Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, ²Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, ³Rheumazentrum Ruhrgebiet, Herne, Germany, ⁴Janssen Research & Development, LLC., Spring House, PA
Background/Purpose: In ankylosing spondylitis (AS), it is hypothesized that stepwise pathologic changes in the spine begin with active inflammation, then fatty degeneration (Fat), leading to…
Abstract Number: 221 • 2013 ACR/ARHP Annual Meeting
Detection Of Cerebral Microvascular Lesions In Patients With Acute Phase Neuropsychiatric Systemic Lupus Erythematosus By 7Tesla MRI
Nobuhito Sasaki¹, Okinori Murata¹, Yukari Ninomiya¹, Yuka Oikawa¹, Hitoshi Kobayashi¹, Kohei Yamauchi¹, Makoto Sasaki², Takashi Sawai³ and Yutaka Nakamura¹, ¹Division of Pulmonary medicine, Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan, ²Division of Ultrahigh Field MRI, Iwate Medical University School of Medicine, Morioka, Japan, ³Department of Pathology, Iwate Medical University School of Medicine, Morioka, Japan
Background/Purpose: The cerebral microvascular lesions of patients with neuropsychiatric systemic lupus erythematosus (NPSLE) have not been fully elucidated. The 7Tesla MR scanner has high image…
Abstract Number: 1041 • 2012 ACR/ARHP Annual Meeting
Whole-Body Magnetic Resonance Imaging – A New Diagnostic Tool in the Assessment of Activity in Juvenile Dermatomyositis Patients?
Tania Monteiro de Castro¹, Henrique Lederman¹, Maria Teresa Terreri², Wanda I. Caldana¹, Edmar Zanoteli³ and Maria Odete Hilario¹, ¹Federal University of São Paulo, São Paulo, Brazil, ²Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, ³University of São Paulo, São Paulo, Brazil
Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disorder, but remains the most commonly chronic inflammatory myopathy among children. A redefinition of the diagnostic criteria…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].